FDA Investigator: Philip F. Istafanos

- Philip F. Istafanos first started conducting FDA inspections in 2000, with the last inspection in 2024. Over that time, Philip F. Istafanos has conducted 34 inspections at 32 companies across 33 sites.

Documents

FDA 483 Icrom, Concorezzo | March 2019

Available - $199
Philip F. Istafanos
Human Drug Form 483

FDA 483 Actavis Italy S.p.A, Nerviano | March 2019

Available - $199
Philip F. Istafanos
Human Drug Form 483

FDA 483 Genentech, Inc., Hillsboro | 2024

Out-of-stock
Philip F. Istafanos
Human Drugs Form 483

FDA 483 Specialty Process Labs LLC, Phoenix | 2024

Out-of-stock
Philip F. Istafanos
Human Drugs Form 483

FDA 483 Panacea Biotec Limited, Baddi, District Solan | 2020

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Sun Pharmaceutical Industries Limited, Mohali | 2020

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Samchundang Pharm Co., Ltd., Hwaseong | 2019

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Pharmascience Inc., La Prairie | 2019

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 PF Consumer Healthcare Canada ULC, Saint-Laurent | 2019

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Aurobindo Pharma Ltd, Bachupally | 2018

Out-of-stock
Philip F. Istafanos
Animal Drugs & Feed Form 483

FDA 483 Pharmaceutical Laboratories and Consultants, Inc., Addison | 2017

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Central Admixture Pharmacy Services Inc, Wallingford | 2016

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Allergan Pharmaceuticals Ireland, Westport | 2015

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Glaxo Operations U.K. Ltd., Barnard Castle | 2015

Out-of-stock
Philip F. Istafanos
Animal Drugs & Feed Form 483

FDA 483 Glaxo Operations U.K. Ltd., Barnard Castle | 2015

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Sonar Products, Inc., Carlstadt | 2015

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 LNK International, Inc., Hauppauge | 2015

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Columbia Presbyterian Medical Center, New York | 2012

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 American Almond Products Co., Inc., Brooklyn | 2009

Out-of-stock
Philip F. Istafanos
Foods & Cosmetic Form 483

FDA 483 Discovery Laboratories Inc., Totowa | 2006

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Par Pharmaceutical Inc., Spring Valley | 2005

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 AstraZeneca LP, Westborough | 2003

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Novartis Pharmaceuticals Corp., Suffern | 2003

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Barr Laboratories, Inc. (subsidiary of Teva Pharmaceuticals), Pomona | 2002

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Allergan Pharmaceuticals Ireland, Westport | 2001

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Astrazeneca, Macclesfield, Cheshire | 2001

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Pharmachemie B.V., Haarlem | 2000

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

FDA 483 Hameln Pharmaceuticals Gmbh, Hameln | 2000

Out-of-stock
Philip F. Istafanos
Human Drug Form 483

Co-Investigators (48)